Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Treasury Shares (2022 - 2025)

Senti Biosciences has reported Treasury Shares over the past 4 years, most recently at $1.1 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 1852.79% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, up 1852.79%, while the annual FY2025 figure was $1.1 million, 1852.79% up from the prior year.
  • Treasury Shares for Q4 2025 was $1.1 million at Senti Biosciences, up from $56423.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $6.8 million in Q2 2022 and troughed at $56423.0 in Q4 2024.
  • A 4-year average of $4.2 million and a median of $5.4 million in 2022 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: crashed 90.63% in 2023 and later skyrocketed 1852.79% in 2025.
  • Year by year, Treasury Shares stood at $5.4 million in 2022, then crashed by 90.63% to $503114.0 in 2023, then tumbled by 88.79% to $56423.0 in 2024, then skyrocketed by 1852.79% to $1.1 million in 2025.
  • Business Quant data shows Treasury Shares for SNTI at $1.1 million in Q4 2025, $56423.0 in Q4 2024, and $503114.0 in Q4 2023.